Article Type
Article
Changed
Tue, 02/01/2022 - 08:47
Author(s)
Neely Mozaffarian
M.D., Ph.D.

In this supplement to OBGM, Neely Mozaffarian discusses how immunology researchers anticipate both improving the therapy for HDFN as well as developing diagnostic tests to identify women for whom HDFN might be an issue.

Click here to read more 

Sponsor
This promotional article was developed in conjunction with and sponsored by The…
Publications
MDedge ObGyn
OBG Management
Sections
Supplements
Author(s)
Neely Mozaffarian
M.D., Ph.D.
Author(s)
Neely Mozaffarian
M.D., Ph.D.
Sponsor
This promotional article was developed in conjunction with and sponsored by The…
Sponsor
This promotional article was developed in conjunction with and sponsored by The…

In this supplement to OBGM, Neely Mozaffarian discusses how immunology researchers anticipate both improving the therapy for HDFN as well as developing diagnostic tests to identify women for whom HDFN might be an issue.

Click here to read more 

In this supplement to OBGM, Neely Mozaffarian discusses how immunology researchers anticipate both improving the therapy for HDFN as well as developing diagnostic tests to identify women for whom HDFN might be an issue.

Click here to read more 

Publications
MDedge ObGyn
OBG Management
Publications
MDedge ObGyn
OBG Management
Article Type
Article
Sections
Supplements
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Information from Industry- Sponsored Supplement
Gate On Date
Wed, 11/17/2021 - 13:00
Un-Gate On Date
Wed, 11/17/2021 - 13:00
Use ProPublica
CFC Schedule Remove Status
Wed, 11/17/2021 - 13:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article